Koto Kawata, Hajime Otsu, Takaaki Masuda, Taro Tobo, Yoshiki Hiraki, Qingjiang Hu et al. Copy Number–Driven COX19 Promotes Colorectal Cancer Growth and Represents a Potential Therapeutic Target of Olmesartan. // Annals of Gastroenterological Surgery. – 2026. – DOI: 10.1002/ags3.70303. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ags3.70303?af=R
Koto Kawata, Hajime Otsu, Takaaki Masuda, Taro Tobo, Yoshiki Hiraki, Qingjiang Hu, Yusuke Yonemura, Koji Ando, Koshi Mimori, & Tomoharu Yoshizumi (2026). Copy Number–Driven COX19 Promotes Colorectal Cancer Growth and Represents a Potential Therapeutic Target of Olmesartan. Annals of Gastroenterological Surgery. https://doi.org/10.1002/ags3.70303
Koto Kawata, et al. “Copy Number–Driven COX19 Promotes Colorectal Cancer Growth and Represents a Potential Therapeutic Target of Olmesartan.” Annals of Gastroenterological Surgery, 2026. doi:10.1002/ags3.70303.
@article{Kawata2026,
title = {Copy Number–Driven COX19 Promotes Colorectal Cancer Growth and Represents a Potential Therapeutic Target of Olmesartan},
author = {Kawata, Koto and Otsu, Hajime and Masuda, Takaaki and Tobo, Taro and Hiraki, Yoshiki and Hu, Qingjiang and Yonemura, Yusuke and Ando, Koji and Mimori, Koshi and Yoshizumi, Tomoharu},
journal = {Annals of Gastroenterological Surgery},
year = {2026},
doi = {10.1002/ags3.70303},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ags3.70303?af=R}
}